Cargando…
VP37 Protein Inhibitors for Mpox Treatment: Highlights on Recent Advances, Patent Literature, and Future Directions
Monkeypox disease (Mpox) has threatened humankind worldwide since mid-2022. The Mpox virus (MpoxV) is an example of Orthopoxviruses (OPVs), which share similar genomic structures. A few treatments and vaccines are available for Mpox. OPV-specific VP37 protein (VP37P) is a target for developing drugs...
Autores principales: | Hudu, Shuaibu A., Alshrari, Ahmed S., Al Qtaitat, Aiman, Imran, Mohd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135999/ https://www.ncbi.nlm.nih.gov/pubmed/37189724 http://dx.doi.org/10.3390/biomedicines11041106 |
Ejemplares similares
-
The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects
por: Alshrari, Ahmed S., et al.
Publicado: (2023) -
Innovations and development of Covid-19 vaccines: A patent review
por: Alshrari, Ahmed S., et al.
Publicado: (2022) -
Hepatitis B Therapeutic Vaccine: A Patent Review
por: Hudu, Shuaibu Abdullahi, et al.
Publicado: (2022) -
Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need
por: Hudu, Shuaibu A., et al.
Publicado: (2023) -
Antibody and immune memory persistence post infant hepatitis B vaccination
por: Hudu, Shuaibu A, et al.
Publicado: (2013)